Palvella Therapeutics (PVLA) Return on Assets: 2014-2024
Historic Return on Assets for Palvella Therapeutics (PVLA) over the last 10 years, with Sep 2024 value amounting to 0.02%.
- Palvella Therapeutics' Return on Assets rose 49.00% to 0.02% in Q3 2024 from the same period last year, while for Sep 2024 it was 0.02%, marking a year-over-year increase of 49.00%. This contributed to the annual value of 0.36% for FY2023, which is 71.00% up from last year.
- Latest data reveals that Palvella Therapeutics reported Return on Assets of 0.02% as of Q3 2024, which was up 110.39% from -0.15% recorded in Q2 2024.
- In the past 5 years, Palvella Therapeutics' Return on Assets registered a high of 0.14% during Q1 2024, and its lowest value of -0.57% during Q1 2023.
- Over the past 3 years, Palvella Therapeutics' median Return on Assets value was -0.40% (recorded in 2022), while the average stood at -0.31%.
- Per our database at Business Quant, Palvella Therapeutics' Return on Assets fell by 25bps in 2021 and then surged by 71bps in 2024.
- Over the past 5 years, Palvella Therapeutics' Return on Assets (Quarterly) stood at -0.30% in 2020, then declined by 2bps to -0.33% in 2021, then decreased by 11bps to -0.44% in 2022, then grew by 14bps to -0.30% in 2023, then spiked by 49bps to 0.02% in 2024.
- Its Return on Assets stands at 0.02% for Q3 2024, versus -0.15% for Q2 2024 and 0.14% for Q1 2024.